Accurate prediction of oral absorption of drugs relies on biorelevant methodology. Current methods are based on Western healthy adult populations. Malnourished children have many differences in their gastrointestinal anatomy and physiology compared to a healthy Western adult. These differences may affect the oral absorption of medicines and it is important to gather knowledge on these GI differences in order to develop biorelevant predictive methods for this vulnerable population.
Introduction
When administering an oral drug product to a patient there are various factors which are important to ensure sufficient drug absorption; these include drug-and formulation-related parameters like drug solubility and permeability, drug product dissolution and gastrointestinal (GI) conditions including the composition and physicochemical properties of GI fluids, transit time and gut wall conditions relevant to metabolism, passive diffusion and active transport of drugs. GI physiology is therefore a key aspect that determines the in vivo performance of orally administered drugs.
Over the last decades, bio-predictive in vitro models have been established for predicting oral drug exposure for a number of compounds in adults after dosing either in fasted or fed conditions. There is a lack of such in vitro models for children, yet they are urgently required to better predict the in vivo performance of medicines in children to minimize the burden of clinical testing. When developing biorelevant in vitro media and models to simulate gastrointestinal conditions, the most appropriate environment needs to be represented. It is already known that there are differences in the gastrointestinal physiology of children in different age groups and in comparison to adults, which are accompanied by variable volumes, pH values and composition [1] ; it is obvious that these differences will be different again in children suffering from diseases affecting GI conditions or in malnourished children.
Malnutrition is a condition that is reported for several patients groups and can be quite common in hospitalized and elderly patients [2] [3] [4] , pregnant and breastfeeding women, and children [5] . Due to their high nutritional requirements children are more susceptible to malnutrition than adults [6] . When designing appropriate bio-predictive in vitro models, it will be essential to consider the specific GI features of malnourished children. To date, a review of the GI conditions in malnourished children is not available. However, it is obvious, that malnutrition will alter the GI environment. An altered GI environment may affect pharmacokinetics of orally administered drugs, which in turn may affect efficacy and subsequent therapy. In basic Table 1 Most common used classification criteria of the nutritional status of children since 1956. -indicates a nutritional status equal to the median for a child of the same gender -≤0.00 indicates a nutritional status that is the indicated number of standard deviations below the median for a child of the same gender and age:
-For example children of 0-5 years -severe malnutrition: any z-scores ≤ −2 -questionable malnutrition: any z-scores > −2 and ≤ −1 -normal weight: all z-scores > −1 -≥0.00 indicates a weight-for-age that is above the median for a child Quantitative classification into mild, moderate and severe categories Z scores reflect the reference distribution and are comparable across ages and indicators [24] Percent-of-median method does not take into consideration the variability in the relative width of the distributions of the different indicators [24] The data used to construct the reference came from a longitudinal study of children (0-3 years) from a single community in the United States. The children have rarely been measured (every 3 months), which is inadequate to describe the rapid and changing rate of growth in early infancy [25] (continued on next page) terms the absorbable dose is influenced by the transit time; concentration of drug at the absorbing surface; surface area available for absorption and the permeability of the drug across the membrane. Differences in any of these parameters will affect the fraction of dose absorbed; hence predictions made in a healthy population may be very different to those where the GI parameters are different. A detailed understanding of the nature of specific GI parameters in malnourished children and of how much they may affect timing, site and extent of in vivo drug release seems to be one of the key factors for developing better oral medications for these children. Moreover, any in vitro and/or in silico models that consider these relevant GI parameters and would be applicable to predict the in vivo performance of orally administered drugs in malnourished children would be extremely beneficial with regard to increasing the safety and efficacy of oral medicines provided to this patient group. The group of malnourished patients describes a heterogenous population. Malnutrition refers to deficiencies, excesses or imbalances in a person's intake of energy and/or nutrients. Malnutrition is divided into undernutrition, which includes stunting, wasting and underweight, and to overweight, which includes obesity and several diet relevant diseases as heart disease and cancer [7] . Undernutrition is caused by a lack of food in general, but also by inadequate, unhealthy diets and diseases including digestive and absorptive disorders resulting in micronutrient deficiencies. It makes children in particular much more vulnerable to disease and death and is responsible for approximately 50% of child mortality for those under five years old [8] In the literature, different criteria that have been applied to classify the nutritional status of children can be found (Table 1 ). According to current WHO criteria undernutrition can be present in 4 broad subforms, i.e. underweight (low weight-for-age), stunting (low height-forage), wasting (low weight-for-height) and deficiencies in vitamins and minerals [7] .
The main hallmark of child malnutrition is growth retardation. Underweight, which represents low weight for age [7] , is defined as a weight-for-age at least two standard deviations below the median weight based on the WHO child growth standards [9, 10] . "Stunting" is a term for chronic undernutrition and reflects low height for age [7] ; defined as less than two standard deviations (SD) below the WHO standards [9, 10] . Acute undernutrition is termed "wasting", where moderate wasting is indicated by a weight between two and three SDs below the WHO standards [9, 10] . Severely wasted children have a weight of less than three SDs below the WHO standards or a mid-upper arm circumference (MUAC) of less than 115 mm in children of 6-60 months [9] [10] [11] .
"Severe wasting" and bilateral oedema are independent diagnostic criteria for severe acute malnutrition (SAM), which is associated with a high risk of death and which requires urgent therapeutic feeding [11] .
Protein-calorie malnutrition (PCM) is a specific subtype of SAM with a deficiency in macronutrients including protein, carbohydrates and fat. The WHO defines PCM, also known as protein energy malnutrition (PEM), as "a pathological condition that results from a lower ingestion of protein and calories, which occurs more frequently in children under five years of age". Severe PCM can be categorized into three principal clinical forms: (i) marasmus, an acute malnutrition characterized by severe wasting of fat and muscle and a gross underweight status; (ii) kwashiorkor presents with moderate growth retardation and bilateral pitting oedema; and (iii) marasmic kwashiorkor, the most severe form of PCM, a mixed form of both marasmus and kwashiorkor that is characterized by the presence of both wasting and bilateral pitting oedema [12] .
PCM is a major public health problem affecting a high proportion of infants and older children worldwide and accounts for a high childhood Z scores reflect the reference distribution and are comparable across ages and indicators [24] Body Mass Index (BMI) Weight in kg divided by square of height in cm:
-BMI percentile for age < 5: underweight -BMI percentile for age ≥ 5 or < 85: healthy weight -BMI percentile for age ≥ 85 or < 95: overweight -BMI percentile > 95: obese morbidity and mortality in the developing countries. Its association with a wide spectrum of infections necessitates multiple drug therapies. Whereas the epidemiology of PCM has been extensively studied globally, the pathophysiological changes that may affect disposition of these drugs in malnourished children have not been reviewed in that much detail [13] . Oshikoya et al. [14] performed a systematic literature review to determine the effects of PCM on drug pharmacokinetics and concluded that there have been relatively few pharmacokinetic studies of drugs frequently used for treatment of children with PCM. However, they also present case examples in which decreased absorption of drugs such as carbamazepine [15] , chloroquine [16] , sulphadiazine [17] , and chloramphenicol [18] have been reported in children with PCM when compared with healthy normal children and was attributed to morphological changes in the jejunum. In addition, treatment failure with artemether-lumefantrine was reported to be due to incomplete absorption in a malnourished child [19] . The aim of this review was to review the available data on the gastrointestinal anatomy and physiology of malnourished children relevant to the performance of orally administered medicines. The focus was set on the screening of the particular features of undernutrition. Thus, in the following sections, the terms malnutrition and undernutrition can be regarded as interchangeable.
Materials and methods
A literature search was conducted within PubMed and Scopus using the search terms listed in Fig. 1 .
Literature that provided original data on parameters that affect GI physiology associated with oral administration and absorption of drugs were included in further analysis. Specifically literature that reported aspects on gastrointestinal transport, motility or contents was sought. Studies where children had co-morbidities were also included in the analysis.
The search was conducted between September 2017 and March 2018. The search results were sorted by the authors (LF and EP-S) based on titles, abstracts or full text articles. Additional literature was obtained from reference lists of the identified articles or reviews on this topic.
For data extraction, studies were sorted according to whether they investigated oral cavity, gastric, small intestinal or large intestinal parameters. Further sorting permitted papers to be reviewed based on physiological parameters of these regions. Data was extracted from relevant papers to gather evidence that was summarized for each absorption parameter. There was too much heterogeneity in the identified literature which did not permit a systematic meta-analysis. Therefore the results could not be presented as a systematic review. Thus, a narrative review was selected to discuss reported effects of malnutrition that would impact on oral drug absorption considering the process from the initiation of oral ingestion to excretion.
Results

Definition of malnutrition used in the papers identified.
The wide range of criteria used to classify malnutrition was highlighted in Table 1 and the papers identified used a range of these criteria when reporting results. The NCHS criteria were the most commonly used with the Gomez index, the Wellcome classification and WHO child growth standards being used in multiple studies [23, [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] .
Oral cavity
The oral cavity is the site of administration for oral medicines. Solid oral dosage forms are usually designed to be swallowed whole and to release the drug in the stomach and/or intestine. However, in children solid oral dosage forms might not be swallowed as rapidly as in adults. Thus, there is a chance that conditions in the oral cavity such as pH, buffer capacity and composition of saliva affect both integrity and drug release from solid oral dosage forms and consequently affect in vivo drug release. Dosage form integrity could be affected by mechanical forces caused by tongue and palate as well as by the volume, pH, buffer capacity and composition of saliva. Salivary pH and buffer capacity also play an important role in dental diseases and compared to healthy children a higher incidence of caries and other dental diseases have been observed in children with poverty driven malnutrition [44, 45] . Increased residence time and drug release in the oral cavity can increase systemic drug absorption across the oral mucosa. Therefore, mucosal integrity is also an important fact to consider when discussing drug administration to malnourished children.
Salivary secretion
Salivary secretion has been reported to be lower in malnourished compared to healthy children (Table 2a) . Agarwal et al. reported that saliva collection took longer (30-40 min) following stimulation with citric acid and strawberry flavor in malnourished children compared to control children or children (aged 1-10 years) with milder forms of PEM (10 min) [30] . Other research found impaired saliva flow rates in severely malnourished children (aged 8-12 years and 11-19 years) in both unstimulated and stimulated conditions [32, 35] . Saliva flow rates were reported to be linked with level of malnutrition and the reduction in flow rate was related to the severity of PEM [35] . However, it should be noted, that malnutrition is often linked with dehydration which independently of malnutrition is known to affect saliva secretion rate [46, 47] .
Saliva pH and buffer capacity
The pH of saliva was reported to be lower (6.9 ± 1.85) in underweight children compared to children of a normal weight (8.1 ± 1.95) (aged 6-12 years) [45] (Table 2b ). In addition a reduction in salivary buffer capacity has been reported for this patient group [23, 32, 45] .
Saliva composition
Concentrations of sodium, potassium, phosphate, hexosamines, fucose, sialic acid and total protein as well as amylase activity in malnourished children have been reported to be similar to those of a control group (aged 8-12 years) [23] (Table 2c ). However, in the malnourished group (aged 8-12 years) significantly lower concentrations of calcium and chloride as well as a decreased amount of protein secreted per minute were found in paraffin-stimulated whole saliva [23] . Agarwal et al. detected a continuous fall of protein, ferritin and arginase activity in stimulated saliva that correlated with the severity of PEM [30] .
Analyses of unstimulated whole saliva show contradictory results regarding the concentrations of total IgA: while Johansson et al. detected no differences in the concentrations of total IgA between the PEM group and the control group; McMurray et al. found reduced IgA concentrations in malnourished children (aged 1.5-2 years) [23, 31] . Salivary total protein, albumin and aminopeptidase were found in similar concentrations in all children by McMurray et al. and, Johansson et al. detected lower concentrations of anti-S. mutans IgA and lactoferrin as well as lower activity of the bacteria agglutinating protein (BAGP) in the PEM group.
Oral mucosa integrity
PEM appears to have multiple effects on the oral tissues and oral disease development [35] . Besides deficiencies in protein malnourished children PEM results in a lack of a number of essential vitamins and minerals that effect structures in the oral cavity. These include folate and other B complex vitamins; vitamins A, C, and D, calcium and fluoride. Consequently, besides impaired dentition, the nutritional status of the body is also associated with disturbances in other oral structures and presents with recurrent aphthous stomatitis, atrophic glossitis, painful, burning tongue characterized by inflammation and defoliation of the tongue, mucosal atrophy and oral ulcers [35, 48, 49] . There is very little data reported on the extent to which oral mucosa integrity is impaired in malnourished children. However, there is evidence that long-term chronic malnutrition causes a significant reduction in resistance and progressive damage to the oral mucosa that will result in reduced resistance to colonization and invasion of pathogenic microorganisms [50] and consequently will most probably also enhance permeability and therefore oromucosal drug absorption.
In summary, the imbalance between the supply of the nutrients and the body's demand results in several oral manifestations that could alter oral drug absorption. However, whereas the impacts on dentition are usually irreversible, in children rehabilitation will most likely result in complete recovery of oral mucosa integrity, saliva secretion and composition.
Stomach
Volume, composition and physicochemical properties of gastric fluids are important factors regarding drug solubility and/or disintegration properties of solid oral dosage forms and thus can affect in vivo drug release. The motility pattern in the stomach and the secretion of gastric juices are directly dependent on food intake. Thus, it is necessary to differentiate between the fasted and fed state. Different nutrition habits or long periods of fasting lead to the assumption that gastric conditions in malnourished children may differ from conditions in healthy children, which may result in altered drug performance.
Gastric contents
Several studies have shown correlations between reduced fasted gastric acid secretion and malnutrition (Table 3a) . Gracey et al. detected, that unstimulated gastric acid secretion was reduced in 9 of 14 malnourished children, while maximal acid output (60 min after pentagastrin stimulation) was below normal in all malnourished patients (aged 7-54 months) [42] . Gilman et al. reported that the fasted gastric acid output was lower in severely malnourished Bangladeshi children compared to better nourished children (0.22 vs 0.52 mEq HCl/h) (aged 3.3 ± 2.4 years) [38] . In the children enrolled in the Gilman study, three weeks of nutritional rehabilitation lead to equivalent rates of fasted gastric acid secretion in the two groups showing that this is a reversible phenomenon [38] . At this point, it also should be noted that as for saliva secretion, impaired gastric secretion may relate to both malnutrition or dehydration of the children, which often cannot be clearly distinguished. Thus, the increase in gastric acid secretion could be also an effect of rehydration. Shashidhar et al. detected a decreased mean acid concentration in malnourished children (aged 12-60 months), here divided into kwashiorkor and marasmic children, under unstimulated and stimulated fasted conditions, although results show a high interindividual variability [51] .
Under unstimulated fasted conditions the pH of gastric juice was above 4 in 76% of malnourished children; After nutritional rehabilitation this decreased to 69% in malnourished children compared to 55% in better-nourished children (aged 3.3 ± 2.4 years) [38] . Under stimulated conditions, the percentage of pH values above 4 was reduced: 26% in malnourished children, 24% in children after nutritional therapy and 0% in better-nourished children [38] . However, pH of gastric juice under stimulated fasted conditions is not equal to gastric pH under fed conditions. Thus, also the composition and quantity of food has an important impact on gastric pH, especially when considering that there are various types of diets worldwide.
Peptic activity was reported to be significantly reduced in malnourished children under fasted conditions compared to well-nourished children (aged 12-60 months) [51] (Table 3a ). Yet, shortly after stimulation of gastric secretion peptic activity rose in all children although it was still significantly decreased in malnourished children.
The reduced gastric output observed at baseline in severely malnourished children correlates to a higher incidence of infections [53] credited to the loss of the gastric acid barrier. The relationship between H. pylori infection and acidity within the stomach is complex; a low level of acidity in the stomach may increase the risk of infection in the gastrointestinal tract and also overgrowth of intestinal bacteria that may lead to diarrhea. The prevalence of H. pylori in children is high in developing countries and since H. pylori infection is associated with an increased gastric pH, it might be associated with malnutrition [38, 54, 55] . Table 3 Gastric parameters. 
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In conclusion, available literature reports reduced gastric acid secretion in malnourished children, yet nutritional rehabilitation seems to result in an immediate improvement. It should be noted that nutritional rehabilitation typically results in rehydration of malnourished children. Malnourished children with watery diarrhea are usually treated with Rehydration Solution for Malnutrition (ReSoMal) [56] . Hence the increase in gastric acid secretion can be caused by both nutritional rehabilitation and rehydration.
Gastric emptying
Investigations on gastric emptying in malnourished children show contradictory results (Table 3b ). Brunser et al. (within a review paper) stated without indicating a reference, that there are clinical observations showing that severe cases of malnutrition are characterized by gastric dilatation, slow emptying and vomiting [52] . Two studies investigating gastric emptying in marasmic, kwashiorkor and marasmic kwashiorkor children (aged 5-29 months and 7-45 months) showed that children with marasmus showed faster gastric emptying of a 5% (w/v) glucose solution administered at a volume of 20 mL/kg body weight compared to a control group. Severely malnourished children with kwashiorkor had no detectable abnormalities in gastric emptying, while in marasmic kwashiorkor children a tendency of delayed gastric emptying was observed [33, 34] . However, the power of these studies is limited, as the patient group was treated with different helminthics such as thiabendazole, which can evoke unspecific gastrointestinal disorders. In contrast, a significantly delayed gastric emptying in both marasmic and marasmic kwashiorkor children (aged 11.97 ± 6.03 months) was reported by Shaaban et al. [41] . In an ultrasonographic study they investigated the impact of nutritional rehabilitation on gastric emptying using a liquid (infant powdered milk formula) and a semisolid meal (milk, rice and high protein additive). They found a clear delay in gastric emptying of both liquid and semisolid food in marasmic and marasmic kwashiorkor children when compared to a control group (aged 11.97 ± 6.03 months). As could be expected, the delay in the gastric half emptying time was higher with the semisolid than with the liquid meals [41] . Nutritional rehabilitation was observed to speed up gastric emptying after 30 ± 7 days of nutritional treatment [41] .
Small intestine
The small intestine is the site where maximal drug absorption occurs. Therefore, small intestinal conditions, such as luminal contents, surface area, transit time and mucosal permeability, can affect drug absorption and this information can help to develop predictive in vitro test designs as accurately as possible.
Small intestinal contents
The small intestinal contents influence the solubility of drugs which in turn will influence their absorption. Key components of small intestinal fluids are bile, enzymes and bacteria.
Mehta et al. analyzed the duodenal contents following a milk stimulus from sixty marasmic children between the ages of 9-42 months. Results showed significantly lower mean concentrations of conjugated bile acids (1.36 mg/mL vs. 2.92 mg/mL) and total bile acids in marasmic children compared to well-nourished children, while the concentration of free bile acids was increased (0.60 mg/mL vs. 0.06 mg/ mL) (Table 4a ). Unfortunately, measured pH values weren't published, but the low pH of duodenal juice was mentioned [43] . Duodenal aspirates were analyzed from 18 severely protein calorie malnourished children (aged 15-64 months) to measure the contents with respect to the ability to achieve micellar solubilisation of lipids. The results showed that micellar lipid and fat absorption were low in PCM children due to lower levels of bile salts [57] . Children under 5 years of age with severe acute malnutrition were shown to have higher total serum bile acids compared to controls which relates to lower biliary secretion within the GI tract [58] .
Sauniere et al. analyzed the duodenal contents of 25 children (1 month to 8 years) with acute symptoms of kwashiorkor. Bicarbonate and volume of duodenal juice of malnourished children were not different compared to the normal African population, while pancreatic enzymes, such as amylase and lipase, were significantly decreased, except for trypsin, which was not affected [59] . These results agree with the findings from 40 children (aged 9-51 months) with kwashiorkor where a wide variation in significant depression of enzyme activity was observed [60] (Table 4b) .
Underproduction of acid in the stomach is the most likely cause of the bacterial overgrowth observed in the small intestine of undernourished children. The impact of high levels of bacteria in the small intestine include impaired nutrient absorption and risks of sub-efficacious oral vaccination in children aged 2 months to 5 years [61] . Several studies have reported higher than usual levels of viable bacteria within the small intestine in malnourished children (aged 9 months to 6 years) [62, 63] (Table 4c ).
Intestinal fluid output and dehydration in malnutrition
The adult small intestine receives large quantities of fluid via dietary fluid intake or as secretions from salivary glands, stomach, pancreas, liver and the small intestine itself. The small intestinal epithelium absorbs about 6-7 L of fluid per day. Only about 1.5 L enter the large intestine and are further reduced to less than 250 mL/day that are excreted with feces. If an individual has diarrhea then osmoregulation is affected and the fluid within the intestine is not reabsorbed and the total intestinal fluid output is elevated to balance the osmolality to favour the absorption [64] . The small intestine is typically a site of net water absorption which has been observed in children with malnutrition. However, in cases of malnutrition that is associated with diarrhea a net secretion of water was measured within the jejunum [65] . This alteration from net absorption to net secretion is likely to reduce the uptake of drugs within the GI tract in cases of diarrhea.
Intestinal permeability
Several studies done in the 1960-1970s showed that the shape of the small intestinal wall changed from regular long villi in healthy patients (villi are structures within the small intestine that increase the small intestinal surface area and, consequently, absorption) to irregular broader and shorter villi in malnourished children (0-3 years) and that the shape in malnutrition is associated with an overall smaller surface area compared to healthy tissue [67, 70, 76] (Table 4e ). However, increased permeation of cellular materials was seen suggesting that the intestine is more permeable in malnutrition [67, 70, 76] . As the severity of malnutrition increases so do the changes in the intestinal epithelium as the abnormalities in marasmus were mild in comparison to children (aged 0-3 years) with kwashiorkor [76] . Atrophy of villi in malnutrition has also been reported [68] [69] [70] .
The Lactulose/Mannitol intestinal permeability test (L:M) is a commonly used technique to measure small intestinal function and can relate to changes in: (a) small intestinal epithelial area; (b) transcellular and paracellular transport and (c) damage and permeability. Mannitol can be used as a marker to assess the mucosal absorptive area and lactulose to assess the integrity of the intestinal membrane. In some studies a lactulose/rhamnose test is used; rhamnose is similar to mannitol in that it is a monosaccharide and mucosal damage will reduce mannitol/rhamnose absorption whilst increasing permeability of lactulose.
A typical reference value for L:M is 0.09 as this was defined as an upper normal limit in 30 healthy Dutch children (aged 0-16 years) [77] ; values greater than 0.09 suggest enteropathy is present. Typically, lactulose (which is large) relates to the overall integrity of the membrane and mannitol can relate to the surface area or overall absorptive capacity of the membrane.
A study on 97 severely underweight Bangladeshi children (mean age 9 years) showed that the difference in mannitol absorption was greater than in lactulose absorption in malnourished children compared to healthy children; this relates to the loss of surface area which is consistent with the shape changes in the villi [27] . Intestinal biopsy studies [70, 78] in malnourished children show that kwashiorkor is associated with villous atrophy, decreased villous-crypt ratio and increased cellularity of the lamina propia; these changes impact the absorptive capacity as well as the overall surface area. Several studies have been conducted to investigate the intestinal permeability of malnourished children with or without diarrhea as well as before and after nutritional rehabilitation [26] [27] [28] 39, 40, 71, 79] . The damaged villi lead to a compromised intestinal wall that can be associated with absorption of large macromolecules that lead to immune-and inflammatory diseases. These diseases further damage the epithelial wall and reduce the barrier for absorption of drugs. Chronic intermittent diarrhea may be linked to carbohydrate malabsorption within the intestine due to the rapid intestinal transit times associated with diarrhea that may limit overall absorption in addition to the differences in the permeability across the membrane [76] . Brewster et al. showed that the combination of increased lactulose permeation and decreased L-rhamnose absorption results in a higher prevalence of diarrhea [71] . Behrens et al. found repeatedly increased intestinal permeability to disaccharides in a number of tests on 68 Gambian infants (aged 0-18 months), most of whom had at least one episode of diarrhea [40] . These findings lead to the conclusion that diarrhea is associated with mucosal damage, which results in compromised small intestinal barrier function and uptake of larger molecules, such as lactulose, through the site of damage [73] . Therefore, diarrhea seems to correlate with abnormally high L/R -ratios and thus with an increased intestinal permeability. Indeed, L/Rratios of patients with diarrhea were observed to be above normal in several studies and correlated with the duration and frequency of diarrheic events and returned to normal with resolution of diarrhea [26, 40, 71] . It can be stated that malnutrition itself is associated with changes in the intestinal mucosa resulting in a reduced absorptive area and malabsorption, while diarrhea, which is often linked to malnutrition, is associated with mucosal damage.
Estimates of the prevalence of impaired intestinal permeability (higher values of L:M) range from 62 to 96% that results in poor growth among infants and young children in developing countries in subSaharan Africa and Asia (urinary L:M concentration ratio > 0.10-0.12) [36, 74, 80] . Perturbed intestinal function is associated with the malabsorption of macro-and micronutrients, including fat, carbohydrates, and vitamins A, B12 and folate [81] [82] [83] . Wessells et al. (2013) study looked at zinc absorption in Burkinabe children (6-23 months) and also measured the lactulose/mannitol measures to assess intestinal integrity. The results showed that the absorption of zinc was linked to the L:M permeability test with a greater proportion of normal children showing higher levels of zinc absorption, however this was only significant different for the most severely affected children [29] .
Intestinal transit time
The transit time through the small intestine is an important factor regarding the absorption of nutrients and drug products, as it affects the time that food and drugs have contact with the absorptive epithelium. In 1999 there was one study conducted regarding orocecal transit time in malnourished children. Myo-Khin et al. [37] used the lactulose breath hydrogen test to investigate orocecal transit in 90 Myanmar children between the ages of 1 and 5 years. After classification according to weight-for-age, length-for-age and weight-for-length indices, 31 children were defined to be malnourished, whose orocecal transit time was compared to transit time in well-nourished children. No significant difference between malnourished and well-nourished children was found. However, children with a history of diarrhea were excluded from the study. As diarrhea and vomiting are two of the most common problems of PEM, as subsequent symptoms, a reduced retention of drugs and decrease of the transit time through the bowel can be expected [13] .
Colon
No literature was identified that reported colonic transit time and colonic permeability in malnourished subjects. There are some studies suggesting that malnutrition is a risk factor for an increased incidence or duration of diarrhea [84] [85] [86] [87] . As a consequence of diarrhea, colonic transit time in malnourished children might be shorter than in healthy children. However, some of the currently available reports on this topic are contradictive and the information available to date is not sufficient for a final conclusion. Another important point to consider in this discussion would be the alterations in the gut microbiome that are reported for severely malnourished children [88] . Future research should thus focus on expanding the knowledge in this field.
Discussion
Malnutrition can affect the gastrointestinal tract and subsequently, modify drug absorption. Therefore, malnutrition can have an indirect impact on drug toxicity or suboptimal therapeutic effects. Clearly, there is a pressing need to understand the impact of malnutrition in drug absorption. Table 5 summarizes the findings from the literature and provides some implications for drug absorption in malnourished children.
The data identified within this search was generally quite old. Some general trends towards alterations in oral, gastric and small intestinal physiology were identified. Next to no information on the colon, another vital section of the GI tract, was available. There is very limited novel data available to really understand the implications of malnutrition on the absorption of orally administered medicines, yet this can be of great importance for such a vulnerable population. A systematic review on the impact of malnutrition on the pharmacokinetics of drugs used in children reported that the extent of absorption was increased in 8 drugs, yet this was attributed to be likely due to changes in clearance rather than the GI physiological changes [14] . However, these statements should be handled with care, since these 8 drugs had significantly different properties with regard to molecular weight, aqueous solubility and permeability in adults and represented candidates from all classes of the biopharmaceutics classification system (BCS). Consequently, at least for some of these APIs plasma levels in malnourished children are likely to be affected by GI physiology.
Moreover, for several other compounds, examples where absorption in malnourished children was unchanged or reduced can be found in the literature [15] [16] [17] [18] .
Current in vitro tools that are used to predict oral drug absorption are based on adult physiologies and Western populations. The simulated gastrointestinal media and biorelevant dissolution methods available to date address GI conditions in fasted and fed healthy European subjects [89] [90] [91] [92] [93] . Biorelevant in vitro tools addressing the particular GI features in malnourished children are currently unavailable. Therefore, there is a real need to develop biorelevant in vitro methods that reflect the conditions found in malnourished children and different types of malnutrition to better understand how drugs are absorbed in these critical and vulnerable populations. This will ensure the selection of adequate doses ensuring a safe and effective drug treatment of these children.
Biorelevant in silico tools using physiologically based pharmacokinetic modelling can provide a tool to better understand the disposition of drugs within a range of populations. There has been some work looking at simulating a malnourished population to explore drug pharmacokinetics [94] . In silico tools permit exploration of predicted pharmacokinetics when considering each different aspect of GI physiology/anatomy for the population under investigation which can provide details on sensitivity to change based on the type of drug presented. Further work is required in this area.
Conclusions
Despite the significance of malnutrition as a global health issue this population has been neglected when considering efficacy of medicines used to treat malnourished children. Oral drug treatment during the acute phase of malnutrition needs to be carefully considered to ensure that the therapy is efficacious. Further work is required to develop biorelevant models that incorporate the findings from this review and to verify these in vitro and in silico models using appropriate pharmacokinetic data. All methods need to acknowledge the heterogeneity of malnutrition as a disease state as well as the age-related changes associated with paediatric populations. constructive suggestions during the preparation of this manuscript. We further would like to show our gratitude to Albertina Arien, Sabine Inghelbrecht and Claire Mackie from Janssen Research and Development for their comments on an earlier version of this manuscript and for proofreading the paper.
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